Table 5.
Medication usage for gastrointestinal conditions after surgery among participants
| Medication usage reported among LOCUS Participants (N = 160) | % |
|---|---|
| Medications to regulate bowel movements (loperamide, codeine) | 99/160 (61 %) |
| Antibiotics (ciprofloxacin, metronidazole) | 23/160 (14 %) |
| Immune-modulating agents (thiopurines, anti-TNF monoclonal antibodies, methotrexate) | 9/160 (6 %) |
| Aminosalicylates | 7/160 (4 %) |
| Proton pump inhibitors | 5/160 (3 %) |
| Analgesics (fentanyl, acetaminophen, gabapentin) | 5/160 (3 %) |
| Supplements (iron, B12, probiotics) | 4/160 (3 %) |
| Antispasmodics (anti-cholinergics) | 4/160 (2 %) |
| Steroids (rectal steroids, prednisone) | 3/160 (2 %) |
| Other medications for heartburn or nausea | 1/160 (2 %) |